These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22900896)

  • 21. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.
    Parrozzani R; Frizziero L; Trainiti S; Testi I; Miglionico G; Pilotto E; Blandamura S; Fassina A; Midena E
    Br J Ophthalmol; 2017 Aug; 101(8):1094-1099. PubMed ID: 27941046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma.
    De Benedetto U; Battaglia Parodi M; Knutsson KA; Librando A; Bandello F; Lanzetta P; Iacono P
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):550-2. PubMed ID: 22554238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of intralesional bevacizumab injection in decreasing pterygium size.
    Fallah Tafti MR; Khosravifard K; Mohammadpour M; Hashemian MN; Kiarudi MY
    Cornea; 2011 Feb; 30(2):127-9. PubMed ID: 20885313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intraocular bevacizumab as palliative therapy in melanoma-metastasis-associated rubeotic secondary glaucoma].
    Jaissle GB; Ulmer A; Henke-Fahle S; Aisenbrey S; Fierlbeck G; Bartz-Schmidt KU; Szurman P
    Klin Monbl Augenheilkd; 2009 Jan; 226(1):70-2. PubMed ID: 19173168
    [No Abstract]   [Full Text] [Related]  

  • 25. Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.
    Ablanedo-Terrazas Y; Alvarado-de la Barrera C; Ormsby CE; Ruiz-Cruz M; Reyes-Terán G
    Laryngoscope; 2015 Apr; 125(4):E132-7. PubMed ID: 25345840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of ocular surface squamous neoplasia with Mitomycin C.
    Gupta A; Muecke J
    Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular surface squamous neoplasia after corneal graft.
    Ramasubramanian A; Shields CL; Sinha N; Shields JA
    Am J Ophthalmol; 2010 Jan; 149(1):62-5. PubMed ID: 19846060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia.
    Rahimi F; Alipour F; Ghazizadeh Hashemi H; Hashemian MN; Mehrdad R
    Arch Iran Med; 2009 Jan; 12(1):55-9. PubMed ID: 19111031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization.
    Yeung SN; Lichtinger A; Kim P; Amiran MD; Slomovic AR
    Cornea; 2011 Oct; 30(10):1110-4. PubMed ID: 21673570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optical coherence tomography angiography in the evaluation of vascular patterns of ocular surface squamous neoplasia during topical medical treatment.
    Theotoka D; Liu Z; Wall S; Galor A; Al Bayyat GJ; Feuer W; Jianhua W; Karp CL
    Ocul Surf; 2022 Jul; 25():8-18. PubMed ID: 35358712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subconjunctival bevacizumab for corneal neovascularization secondary to topical anesthetic abuse.
    Georgakopoulos CD; Vasilakis P; Makri OE; Beredima E; Pharmakakis N
    Cutan Ocul Toxicol; 2011 Dec; 30(4):320-2. PubMed ID: 21517719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intralesional bevacizumab for cutaneous capillary haemangioma associated with pregnancy.
    Steeples LR; Bonshek R; Morgan L
    Clin Exp Ophthalmol; 2013; 41(4):413-4. PubMed ID: 22957786
    [No Abstract]   [Full Text] [Related]  

  • 33. Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients.
    Kaliki S; Singh S; Iram S; Tripuraneni D
    Indian J Ophthalmol; 2016 Oct; 64(10):702-709. PubMed ID: 27905329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional and anatomic changes in bilateral choroidal neovascularization associated with vitelliform macular dystrophy after intravitreal bevacizumab.
    Cennamo G; Cesarano I; Vecchio EC; Reibaldi M; de Crecchio G
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):643-6. PubMed ID: 22742532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
    Hirst LW
    Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of topical bevacizumab for conjunctival intraepithelial neoplasia.
    Özcan AA; Çiloğlu E; Esen E; Şimdivar GH
    Cornea; 2014 Nov; 33(11):1205-9. PubMed ID: 25014150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy.
    Karnezis TT; Davidson TM
    Laryngoscope; 2012 Mar; 122(3):495-7. PubMed ID: 22147664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular Surface Squamous Neoplasia in Papillon-Lefèvre Syndrome: Outcome at Long-Term Follow-Up of 12 Years.
    Kaliki S; Singh S; Gowrishankar S; Reddy VAP
    Cornea; 2017 Jun; 36(6):743-746. PubMed ID: 28350623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of pterygium by ligation and bevacizumab injection.
    Nakasato H; Uemoto R; Mizuki N
    Cornea; 2012 Nov; 31(11):1339-41. PubMed ID: 22710493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunctive bevacizumab therapy in an equine corneal stromal invasive squamous cell carcinoma with a 53-months follow-up.
    Blohm KO; Nell B
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2024 Apr; 52(2):108-114. PubMed ID: 38701802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.